Winnow Wealth’s Globus Medical GMED Stock Holding History

Winnow Wealth’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30	Closed	-$2.64K	–	305
2025 Q4	$2.64K	Buy	+30	New	+$2.28K	﹤0.01%	341

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winnow Wealth's GMED Position: Q1 2026 in Review

Winnow Wealth sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 30 shares — an estimated $2.64K sold.

Winnow Wealth first reported a position in GMED in Q4 2025 and held it in 1 quarter. The position peaked at $2.64K in Q4 2025. 611 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Winnow Wealth reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
Winnow Wealth sold 30 Globus Medical shares in Q1 2026, an estimated $2.64K.
Winnow Wealth first reported a position in Globus Medical in Q4 2025 and held it in 1 quarter.
Winnow Wealth's Globus Medical position peaked at $2.64K in Q4 2025.
611 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.